Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

What "newest" means here

The most recent study in this library is dated 2026-11-01 (Paths of Aging Minds: Health Journeys of Older Adults with Mild Cognitive Impairment). This is our summary library, not a news wire — it is added to in batches, so the newest entry may not be the newest paper published anywhere.

Entries are sorted strictly by publication date, newest first. 26489 of the 27380 entries carry a full day-level date. 65 have no date recorded at all and are placed by publication year, at the start of that year; those are marked "no date recorded" below so you can see where the ordering is a best effort rather than a fact.

Prefer a reader? Subscribe to the Atom feed. Want them sorted by subject or by score instead? Browse the research library.

Showing 13,826–13,850 of 27,380 studies, newest first · page 554 of 1096.

July 2018 25

  1. 2018-07-19
  2. 2018-07-18

    Liraglutide for psychiatric disorders: clinical evidence and challenges

    ✓ Peer-reviewed Drug development Hormone molecular biology and clinical investigation

    Key finding: Preliminary clinical evidence has suggested that liraglutide could decrease weight gain, improve cognition and prevent cognitive decline.

  3. 2018-07-18

    Discovery and validation of autosomal dominant Alzheimer's disease mutations

    ✓ Peer-reviewed Risk genes beyond APOE Alzheimer's research & therapy

    Key finding: We propose that PSEN1 M84V, PSEN1 A396T, PSEN2 R284G, and APP T719N are likely pathogenic mutations, whereas PSEN1 c.379_382delXXXXinsG and PSEN2 L238F have uncertain pathogenicity. +2 more findings

  4. 2018-07-18

    Transcranial direct current stimulation combined with cognitive training for the treatment of Parkinson Disease: A randomized, placebo-controlled study

    ✓ Peer-reviewed Prevention trials Brain stimulation

    Key finding: We concluded that cognitive training along with active tDCS is a useful combined approach in the management of mood and cognitive dysfunctions in PD. +3 more findings

  5. 2018-07-18

    Alzheimer disease pathology and the cerebrospinal fluid proteome

    ✓ Peer-reviewed Tau biomarkers Alzheimer's research & therapy

    Key finding: Altered proteome profiles have been reported in both postmortem brain tissues and body fluids of subjects with Alzheimer disease (AD), but their broad relationships with AD pathology, amyloid pathology, and tau-related neurodegeneration have not yet been fully explored. +3 more findings

  6. 2018-07-17

    Sleep disturbances and dementia risk: A multicenter study

    ✓ Peer-reviewed Risk factors Alzheimer's & dementia : the journal of the Alzheimer's Association

    Key finding: Midlife insomnia (fully adjusted hazard ratio = 1.24, 95% confidence interval = 1.02-1.50) and late-life terminal insomnia (fully adjusted odds ratio = 1.94, 95% confidence interval = 1.08-3.49) were associated with a higher dementia risk. +2 more findings

  7. 2018-07-17

    Left lateralized cerebral glucose metabolism declines in amyloid-β positive persons with mild cognitive impairment

    ✓ Peer-reviewed Long-term cohort studies NeuroImage. Clinical

    Key finding: Previous publications indicate that Alzheimer's Disease (AD) related cortical atrophy may develop in asymmetric patterns, with accentuation of the left hemisphere. +3 more findings

  8. 2018-07-17

    The role of TREM2 in Alzheimer's disease and other neurodegenerative disorders

    ✓ Peer-reviewed TREM2 and immune genetics The Lancet. Neurology

    Key finding: TREM2 is a transmembrane receptor expressed in cells of the myeloid lineage, and its association with Alzheimer's disease supports the involvement of immune and inflammatory pathways in the cause of the disease, rather than as a consequence of the disease. +3 more findings

  9. 2018-07-17

    Transplanted neural-like cells improve memory and Alzheimer-like pathology in a rat model

    ✓ Peer-reviewed Biomarkers Cytotherapy

    Key finding: It should be noted that by improving the neuronal connectivity in AM rat brains, the transplanted NLCs rescue Alzheimer's cognition.

  10. 2018-07-15
  11. 2018-07-14

    Cohort Profile Update: The Irish Longitudinal Study on Ageing (TILDA)

    ✓ Peer-reviewed End-of-life care International Journal of Epidemiology

    Key finding: As outlined in the original cohort profile,1 The Irish Longitudinal Study on Ageing (TILDA) is a prospective cohort study designed to provide an evidence base for addressing the challenges and opportunities associated with population ageing in Ireland. +3 more findings

  12. 2018-07-13

    Involvement of Hospitalized Persons With Dementia in Everyday Decisions: A Dyadic Study

    ✓ Peer-reviewed Caregiving The Gerontologist

    Key finding: Both members of the dyad rated the PWD, on average, as being "somewhat involved". +4 more findings

  13. 2018-07-12

    Brain-wide glymphatic enhancement and clearance in humans assessed with MRI

    ✓ Peer-reviewed How common it is JCI insight

    Key finding: Standardized T1-weighted MRI scans were performed before and after intrathecal gadobutrol at defined time points, including at 24 hours, 48 hours, and 4 weeks. +4 more findings

  14. 2018-07-11

    A molecular approach in drug development for Alzheimer's disease

    ✓ Peer-reviewed Treatments Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

    Key finding: An increase in dementia numbers and global trends in population aging across the world prompts the need for new medications to treat the complex biological dysfunctions, such as neurodegeneration associated with dementia.

  15. 2018-07-11

    How can a measure improve assessment and management of symptoms and concerns for people with dementia in care homes? A mixed-methods feasibility and process evaluation of IPOS-Dem

    ✓ Peer-reviewed End-of-life care PloS one

    Key finding: Key mechanisms of action were: improved observation and awareness of residents, collaborative assessment, comprehensive 'picture of the person', systematic record keeping, improved review and monitoring, care planning and changes to care provision, and facilitated multi-agency communication.

  16. 2018-07-11

    Deficiency in the transcription factor NRF2 worsens inflammatory parameters in a mouse model with combined tauopathy and amyloidopathy

    ✓ Peer-reviewed Biomarkers Redox biology

    Key finding: Daily oral gavage of DMF during six weeks reduced glial and inflammatory markers and improved cognition and motor complications in the AT-NRF2-WT mice compared with the vehicle-treated animals.

  17. 2018-07-10

    Patient perspectives of the experience of a computerized cognitive assessment in a clinical setting

    ✓ Peer-reviewed Cognitive tests and assessment Alzheimer's & dementia (New York, N. Y.)

    Key finding: Careful design and user-testing should be made a priority in the development of computerized assessment interfaces, as well as reevaluating the cognitive assessment process to minimize patient anxiety and discomfort. +1 more finding

  18. 2018-07-09

    Cellular Stresses and Stress Responses in the Pathogenesis of Insulin Resistance

    ✓ Peer-reviewed Disease mechanisms Oxidative medicine and cellular longevity

    Key finding: Its etiological pathways are not well defined, although many contributory mechanisms have been established. +4 more findings

  19. 2018-07-09

    A rare loss-of-function variant of ADAM17 is associated with late-onset familial Alzheimer disease

    ✓ Peer-reviewed Genetics Molecular psychiatry

    Key finding: Subsequent genotyping and analysis of available whole-exome sequencing data of additional case/control samples from Germany, UK, and USA identified five variant carriers among AD patients only. +4 more findings

  20. 2018-07-09

    Graphene quantum dots prevent α-synucleinopathy in Parkinson's disease

    ✓ Peer-reviewed Lewy body dementia Nature nanotechnology

    Key finding: Though emerging evidence indicates that the pathogenesis of Parkinson's disease is strongly correlated to the accumulation 1,2 and transmission 3,4 of α-synuclein (α-syn) aggregates in the midbrain, no anti-aggregation agents have been successful at treating the disease in the clinic.

  21. 2018-07-09

    CogChamps: impact of a project to educate nurses about delirium and improve the quality of care for hospitalized patients with cognitive impairment

    ✓ Peer-reviewed Health systems and care delivery BMC Health Services Research

    Key finding: Observational and audit data were collected for 181 patients (average age = 82.5 years) across the two hospitals. +4 more findings

  22. 2018-07-09

    TREM2-Dependent Effects on Microglia in Alzheimer's Disease

    ✓ Peer-reviewed TREM2 and immune genetics Frontiers in aging neuroscience

    Key finding: Abnormal protein aggregates in the AD brain are also associated with reactive microglia and astrocytes. +3 more findings

  23. 2018-07-09

    Unsupervised Machine Learning to Identify High Likelihood of Dementia in Population-Based Surveys: Development and Validation Study

    ✓ Peer-reviewed Digital health tools Journal of medical Internet research

    Key finding: Unsupervised machine learning identifies high likelihood of dementia in population-based surveys, even without cognitive and behavioral measures and without the need of clinical diagnosis of dementia in a subsample of the population. +1 more finding

  24. 2018-07-05

    Klotho at the Edge of Alzheimer's Disease and Senile Depression

    ✓ Peer-reviewed Risk factors Molecular neurobiology

    Key finding: Klotho, encoded by the KL gene, is a single-pass transmembrane protein and a circulating factor that plays a key role in cellular metabolism and body homeostasis and has been associated with age-related diseases.

  25. 2018-07-05

    Strong Circadian Rhythms in the Choroid Plexus: Implications for Sleep-Independent Brain Metabolite Clearance

    ✓ Peer-reviewed Risk factors Journal of experimental neuroscience

    Key finding: CSF dilutes metabolites from neuronal activities and removes them from the brain. +4 more findings

Browse the library by subject, with the full score breakdown →